inflammatory bowel disease
Conditions
Interventions
Control group:pseudoacupuncture
Experimental group:SGTS integrated acupuncture
Sponsors
Guangdong Provincial Traditional Chinese Medicine Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: (1) Patients with IBD who meet the diagnostic criteria; (2) Patients who meet the diagnostic criteria for mild to moderate anxiety and depression. The score for HAMD-17 ranges from 7 to 24, and/or the score for HAMA-14 ranges from 14 to 29; (3) Age ranges from 18 to 80 years old, with no gender restrictions; (4) Not participating in any other ongoing clinical trials; (5) Voluntarily signing the relevant informed consent form.
Exclusion criteria
Exclusion criteria: (1) Patients with unclear consciousness or understanding disorders; (2) Patients who cannot perform acupuncture due to skin damage and other diseases in the body surface area of the acupoints involved in this study; (3) diabetic patients with peripheral nerve function impairment; (4) Patients with serious diseases of heart, brain, liver, kidney and hematopoietic system; (5) Suicide risk cannot be ruled out; (6) Women who are pregnant, breastfeeding or preparing for pregnancy during the observation period; (7) Poor compliance or fear of acupuncture (Note: Patients who meet any 1 of the above criteria are excluded.)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| HAMD;HAMA; | — |
Secondary
| Measure | Time frame |
|---|---|
| CDAI;IBDQ;Mayo; | — |
Countries
China
Contacts
Public ContactDing Luo
Guangdong Provincial Traditional Chinese Medicine Hospital
Outcome results
None listed